Evidence map›Paper›PMID 36925821›Full record

ArticleFrontiers in health services2022

Economic Analysis of Low Volume Interventions Using Real-World Data: Costs of HIV Self-Testing Distribution and HIV Testing Services in West Africa From the ATLAS Project.

Métogara Mohamed Traore, Kéba Badiane, Anthony Vautier, Arlette Simo Fotso, Odé Kanku Kabemba, Nicolas Rouveau, Mathieu Maheu-Giroux, Marie-Claude Boily, Joseph Larmarange, Fern Terris-Prestholt and 1 more

Open access · diamondFull text read
In one paragraph

Article in Frontiers in health services, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 4 countries.

Métogara Mohamed TraoreSolidarité Thérapeutique et Initiative pour la Santé, Abidjan, Côte d'Ivoire.
Kéba BadianeSolidarité Thérapeutique et Initiative pour la Santé, Dakar, Senegal.
Anthony VautierSolidarité Thérapeutique et Initiative pour la Santé, Dakar, Senegal.
Arlette Simo FotsoCentre Population et Développement (Ceped), Institut de Recherche pour le Développement (IRD), Université de Paris, Inserm, Paris, France.
Odé Kanku KabembaSolidarité Thérapeutique et Initiative pour la Santé, Bamako, Mali.
Nicolas RouveauCentre Population et Développement (Ceped), Institut de Recherche pour le Développement (IRD), Université de Paris, Inserm, Paris, France.
Mathieu Maheu-GirouxDepartment of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, McGill University, Montréal, QC, Canada.
Marie-Claude BoilyDepartment of Infectious Disease Epidemiology, Medical Research Council Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom.
Joseph LarmarangeCentre Population et Développement (Ceped), Institut de Recherche pour le Développement (IRD), Université de Paris, Inserm, Paris, France.
Fern Terris-PrestholtDepartment of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Marc d'ElbéeDepartment of Global Health in the Global South, Bordeaux Population Health, Institut National de la Santé et de la Recherche Médicale (Inserm), University of Bordeaux, Bordeaux, France.
Pour la Solidarité · BECentre Population et Développement · FRInserm · FRInstitut de Recherche pour le Développement · FRLondon School of Hygiene & Tropical Medicine · GBMcGill University · CAMedical Research Council · GBUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Achieving the first 95 of the UNAIDS targets requires the implementation of innovative approaches to knowing one's HIV status. Among these innovations is the provision of HIV self-testing (HIVST) kits in west Africa by the international partner organization Solthis (IPO). In order to provide guidance for the optimal use of financial resources, this study aims to estimate the program and site level costs of dispensing HIVST as well as HIV testing services (HTS)-excluding HIVST-in health facilities in Côte d'Ivoire, Mali and Senegal as part of the ATLAS project. We estimated from the provider's perspective, HIVST and HTS incremental costs using top-down and bottom-up costing approaches and conducted a time and motion study. We identified costs at the

Indexed as

cost analysisCôte d'Ivoirehealth facilitiesHIV self-testingHIV testing servicesMalireal-world dataSenegal

Identifiers

PMID36925821
PMCPMC10012764
OpenAlexW4283589463

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read114
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.